跳至主要内容
临床试验/CTRI/2024/02/062420
CTRI/2024/02/062420招募中4 期

A, Single centric, assessor blinded randomized study to compare the repigmentingefficacy of topical Tofacitinib gel/ ointment with topical Tacrolimus gel/ ointment infacial vitiligo . - Nil

Dr Imran Majid0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with a confirmed diagnosis of Facial vitiligo for any duration, Body surface area involvement <5%, Washout period of 1 week in case of topical therapy for Vitiligo and 1 month
  • washout period for Systemic therapy for vitiligo before enrolment, Written informed consent signed by the patient or legally acceptable
  • representative(s) in line with applicable regulation of country, Planned treatment in line with the Summary of Product Characteristics

排除标准

  • any contraindication to any of the topical medications, women of childbearing age, pregnancy, lactation, hypersensitivity to any of the topical agents, unwillingness to conform to study protocol

研究者

发起方
Dr Imran Majid

相似试验